Revenio Group Oyj (LON:0KFH)
London
· Delayed Price · Currency is GBP · Price in EUR 27.16
-0.65 (-2.33%)
At close: Feb 19, 2025
Revenio Group Oyj Revenue
In the year 2024, Revenio Group Oyj had annual revenue of 103.80M EUR with 7.25% growth. Revenio Group Oyj had revenue of 30.70M in the quarter ending December 31, 2024, with 4.48% growth.
Revenue
103.80M EUR
Revenue Growth
+7.25%
P/S Ratio
n/a
Revenue / Employee
430.71K EUR
Employees
241
Market Cap
583.60M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 103.80M | 7.02M | 7.25% |
| Dec 31, 2023 | 96.79M | -445.00K | -0.46% |
| Dec 31, 2022 | 97.23M | 17.88M | 22.53% |
| Dec 31, 2021 | 79.36M | 18.04M | 29.43% |
| Dec 31, 2020 | 61.31M | 11.60M | 23.34% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| Hikma Pharmaceuticals | 2.39B |
| ConvaTec Group | 1.74B |
| HUTCHMED (China) | 483.31M |
| Genus | 668.80M |